Clinical Study

Evaluation of the Macular, Peripapillary Nerve Fiber Layer and Choroid Thickness Changes in Behçet’s Disease with Spectral-Domain OCT

Table 2

Thickness of macula in patients with BD and controls.

VariablesGroupsOcular Involvement
Control ( )Behcet ( ) Present ( )Absent ( )

CSF269.30 ± 20.05266.76 ± 22.870.425266 ± 23.07269 ± 20.510.606
SIM348.75 ± 16.48340.95 ± 19.370.004336.41 ± 18.17342.05 ± 19.250.271
TIM333.46 ± 14.00326.41 ± 16.850.003327.73 ± 15.3326.84 ± 16.260.836
IIM342.57 ± 18.77336.47 ± 20.800.038336.86 ± 17.96335.81 ± 26.530.870
NIM348.28 ± 14.12338.38 ± 22.48<0.001338.68 ± 21.68339.62 ± 21.030870
SOM301.03 ± 15.21294.23 ± 17.930.006287.95 ± 16.94297.43 ± 15.310.031
TOM288.47 ± 15.16283.90 ± 20.090.089279 ± 16.46286.3 ± 14.420.080
IOM294.44 ± 16.53287.95 ± 19.260.016285 ± 31.15289.97 ± 14.830.488
NOM319.07 ± 15.07310.18 ± 20.100.001305.64 ± 17.84312.24 ± 21.130.224
FOVEA226.46 ± 24.78225.59 ± 30.670.492218.18 ± 25.83230.16 ± 31.20.135

Values are expressed as mean ± SD; : number of case; CSF: central subfield; SIM: superior inner macula; TIM: temporal inner macula; IIM: inferior inner macula; NIM: nasal inner macula; SOM: superior outer macula; TOM: temporal outer macula; IOM: inferior outer macula; NOM: nasal outer macula.